VFA
6 data points extracted from 1 publication by this organisation.
Data points
6
Documents
1
Indicators
6
Regions
1
Publisher type
Industry association
Bibliography
Documents used
Every publication we have taken a number from, with the date we read it and the link status at that time.
| Document | Type | Published | Retrieved | Link | Data points |
|---|---|---|---|---|---|
| Neue Medikamente in Deutschland: Innovationsbilanz 2025 Licence: See source | Press release | — | 17 Sep 2026 | Reachable | 6 |
Every figure
Data points
Every figure taken from this organisation, grouped by indicator.
| Indicator | Region | Period | Value | Type | Full record |
|---|---|---|---|---|---|
| Chemically synthesized share of new medicine launches | Germany | 2025 | 57% | actual | → |
| Genetically engineered share of new medicine launches | Germany | 2025 | 41% | actual | → |
| Label extensions for approved medicines | Germany | 2025 | 20 | actual | → |
| New medicines launched with orphan drug designation | Germany | 2025 | 14 | actual | → |
| New rare disease drug launches | Germany | 2025 | 25 | actual | → |
| Novel active substance launches | Germany | 2025 | 37 | actual | → |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. Credit VFA as the original publisher; each record page carries its own citation.
VFA. Retrieved from StatOrigin: https://statorigin.org/sources/vfa
Keep exploring
Related
Industries using this source
Last verified 17 September 2026. Link status is rechecked weekly.